AACR
-
Grant bolsters kidney cancer immunotherapy research
W. Kimryn Rathmell, MD, PhD, Cornelius Abernathy Craig Professor of Medicine and director of the Division of Hematology and Oncology at Vanderbilt-Ingram Cancer Center (VICC), has received a grant to research the role of immunosuppression in the tumor microenvironment for kidney cancer. Read MoreMay 10, 2018
-
Study to test combination therapy for breast cancer
Vanderbilt-Ingram Cancer Center (VICC) has received $2.3 million to fund a clinical research trial testing a combination of three immunotherapy compounds for patients with a specific type of advanced breast cancer. Read MoreOct 26, 2017
-
Project reveals importance of cancer gene mutation testing
An international genomic data-sharing consortium has analyzed nearly 19,000 patient genomic records and found that testing of patient tumors for relevant gene mutations often provides a roadmap for the use of effective therapies. Read MoreJun 8, 2017
-
VICC joins cancer genomic data sharing initiative
Vanderbilt-Ingram Cancer Center (VICC) has joined an international consortium of leading cancer centers to share genomic data from patients in an effort to accelerate the pace of cancer research and improve precision medicine. Read MoreJan 19, 2017
-
VICC investigators in spotlight at AACR conference
A top Vanderbilt-Ingram Cancer Center (VICC) investigator recently met with Vice President Joe Biden regarding the National Cancer Moonshot Initiative, a major national program to identify, fund and accelerate the most promising research leading to cancer cures. Read MoreMay 19, 2016
-
DISSECTing cell signaling networks
Vanderbilt researchers have developed a new method to study cell signaling networks at single-cell resolution. Read MoreDec 14, 2015
-
Exercise during teen years linked to lowered risk of cancer death later
Women who exercised during their teen years were less likely to die from cancer and all other causes during middle-age and later in life, according to a new study by investigators at Vanderbilt University Medical Center and the Shanghai Cancer Institute in China. Read MoreAug 4, 2015
-
Arteaga, AACR push for cancer research funding
Carlos L. Arteaga, M.D., director of the Center for Cancer Targeted Therapies and director of the Breast Cancer Program at Vanderbilt-Ingram Cancer Center (VICC), recently joined other cancer research leaders in a meeting with members of Congress to discuss precision medicine in cancer and the need for continued federal support for cancer research. Read MoreJul 9, 2015
-
Jansen’s cancer research efforts garner recognition
Valerie Malyvanh Jansen, M.D., Ph.D., a third-year medical oncology fellow, recently received several national awards and grants, as well as a Vanderbilt-Ingram Cancer Center fellowship, in recognition of her translational cancer research. Read MoreMay 14, 2015
-
VICC cancer research efforts in spotlight at AACR conference
Adding an investigational drug to an already approved estrogen blocking therapy appears to be safe and provided clinical benefit for some postmenopausal women with estrogen-positive breast cancer. Read MoreApr 30, 2015
-
Cancer organizations call for regulation of e-cigarettes
Two leading cancer organizations are calling for regulation of e-cigarettes and other electronic nicotine delivery systems (ENDS). Read MoreJan 15, 2015
-
Cancer progress report calls for added research support
There are now approximately 14.5 million cancer survivors in the United States, thanks in large part to advances in cancer research and the development of new anti-cancer therapies. Read MoreSep 25, 2014
-
VICC research takes center stage at national meeting
Research led by Joan Garrett, Ph.D., research instructor in Hematology/Oncology, reveals a molecular mechanism that may explain why some forms of breast cancer become resistant to therapy. Read MoreApr 24, 2014
-
VICC’s Arteaga assumes presidency of AACR
Carlos L. Arteaga, M.D., professor of Medicine and Cancer Biology and Donna S. Hall Professor of Breast Cancer Research at Vanderbilt-Ingram Cancer Center (VICC), assumed the presidency of the American Association for Cancer Research (AACR) for 2014-2015 during the group’s annual meeting last week in San Diego. Read MoreApr 17, 2014
-
VU study identifies DNA changes in drug-resistant cancer cells
Vanderbilt investigators have combined next-generation sequencing technologies and bioinformatics analyses to screen for genome-wide genetic mutations associated with drug resistance in a series of lung cancer cell lines. Read MoreSep 12, 2013
-
Moses receives AACR’s lifetime achievement in research award
Harold L. (Hal) Moses, M.D., professor of Medicine and Pathology, acting chair of Cancer Biology and director emeritus of Vanderbilt-Ingram Cancer Center (VICC), has received the 10th annual American Association for Cancer Research (AACR) Award for Lifetime Achievement in Cancer Research. Read MoreApr 11, 2013
-
Moses named to inaugural class of AACR fellows
Harold L. (Hal) Moses, M.D., professor and acting chair of Cancer Biology and professor of Medicine and Pathology, Microbiology and Immunology, has been named to the first class of the Fellows of the American Association for Cancer Research (AACR) Academy. Read MoreMar 28, 2013